Temaz and Decreased activity - a phase IV clinical study of FDA data
Summary:
Decreased activity is reported as a side effect among people who take Temaz (temazepam), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Viread, and have Hiv infection.
The phase IV clinical study analyzes which people have Decreased activity when taking Temaz. It is created by eHealthMe based on reports of 40,916 people who have side effects when taking Temaz from the FDA, and is updated regularly.
What is Temaz?
Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,290 Temaz users. Check the latest studies of Temaz.
What is Decreased activity?
Decreased activity is found to be associated with 1,284 drugs and 1,305 conditions by eHealthMe. Check the latest studies of Decreased activity.
40,916 people reported to have side effects when taking Temaz.
Among them, 46 people (0.11%) have Decreased activity.

Among these 46 people:
How long have people been on Temaz when they have Decreased activity? *
- < 1 month: 33.33 %
- 1 - 6 months: 33.33 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 33.33 %
- 10+ years: 0.0 %
What is the gender of people who have Decreased activity when taking Temaz? *
- female: 56.1 %
- male: 43.9 %
What is the age of people who have Decreased activity when taking Temaz? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 3.03 %
- 30-39: 18.18 %
- 40-49: 24.24 %
- 50-59: 18.18 %
- 60+: 36.36 %
What are other drugs people take besides Temaz? *
- Viread: 14 people, 30.43%
- Norvir: 12 people, 26.09%
- Truvada: 11 people, 23.91%
- Tivicay: 11 people, 23.91%
- Kaletra: 10 people, 21.74%
- Epivir: 10 people, 21.74%
- Zolpidem: 9 people, 19.57%
- Atripla: 9 people, 19.57%
- Lipitor: 9 people, 19.57%
- Calcium: 8 people, 17.39%
What are other side effects people have besides Decreased activity? *
- Pain: 26 people, 56.52%
- Stress And Anxiety: 24 people, 52.17%
- Anhedonia (inability to experience pleasure from activities usually found enjoyable): 23 people, 50.00%
- Emotional Distress: 21 people, 45.65%
- Fatigue (feeling of tiredness): 19 people, 41.30%
- Quality Of Life Decreased: 18 people, 39.13%
- Acute Kidney Failure: 13 people, 28.26%
- Weakness: 12 people, 26.09%
- Depression: 11 people, 23.91%
- Osteoporosis (bones weak and more likely to break): 10 people, 21.74%
What are the existing conditions these people have? *
- Hiv Infection: 20 people, 43.48%
- Depression: 6 people, 13.04%
- Pain: 6 people, 13.04%
- Irritable Bowel Syndrome: 2 people, 4.35%
- Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 2 people, 4.35%
- Hypersensitivity: 2 people, 4.35%
- Asthma: 2 people, 4.35%
- Stress And Anxiety: 2 people, 4.35%
- Bacterial Infection: 2 people, 4.35%
- High Blood Pressure: 2 people, 4.35%
* Approximation only. Some reports may have incomplete information.
Do you take Temaz and have Decreased activity?
- Check whether Decreased activity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Temaz:
- Temaz (42,290 reports)
Decreased activity treatments and more:
- Decreased activity (15,466 reports)
How severe was Decreased activity and when was it recovered:
Expand to all the drugs that have ingredients of temazepam:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Temaz:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Decreased activity:
- Decreased activity (1,284 drugs)
Browse all the conditions that are associated with Decreased activity:
- Decreased activity (1,305 conditions)
Drugs similar to Temaz and Decreased activity :
- Ambien side effect: Decreased activity
- Ambien cr side effect: Decreased activity
- Amitriptyline hydrochloride side effect: Decreased activity
- Ativan side effect: Decreased activity
- Benadryl side effect: Decreased activity
- Clonazepam side effect: Decreased activity
- Clonidine side effect: Decreased activity
- Desyrel side effect: Decreased activity
- Diphen side effect: Decreased activity
- Diphenhydramine hydrochloride side effect: Decreased activity
- Doxepin hydrochloride side effect: Decreased activity
- Doxylamine succinate side effect: Decreased activity
- Hydramine side effect: Decreased activity
- Hydroxyzine side effect: Decreased activity
- Klonopin side effect: Decreased activity
- Loraz side effect: Decreased activity
- Lorazepam side effect: Decreased activity
- Lunesta side effect: Decreased activity
- Magnesium side effect: Decreased activity
- Melatonin side effect: Decreased activity
- Mirtazapine side effect: Decreased activity
- Quetiapine fumarate side effect: Decreased activity
- Remeron side effect: Decreased activity
- Seroquel side effect: Decreased activity
- Trazodone hydrochloride side effect: Decreased activity
- Unisom side effect: Decreased activity
- Xanax side effect: Decreased activity
- Zolpidem side effect: Decreased activity
- Zolpidem tartrate side effect: Decreased activity
- Zopiclone side effect: Decreased activity
How the study uses the data?
The study uses data from the FDA. It is based on temazepam (the active ingredients of Temaz) and Temaz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Neurontin cause Seroma? - 2 seconds ago
- Xeljanz and High Blood Cholesterol for Women aged 20-29 - 14 seconds ago
- Xeljanz and Ldl/Hdl Ratio Increased for Women aged 20-29 - 14 seconds ago
- Xeljanz and Lipid Disorders for Women aged 20-29 - 15 seconds ago
- Xeljanz and Hyperlipoproteinemia for Women aged 20-29 - 15 seconds ago
- Xeljanz and Hyperlipidemia for Women aged 20-29 - 15 seconds ago
- Xeljanz and High Blood Cholesterol And Triglycerides for Women aged 20-29 - 16 seconds ago
- Xeljanz and Blood Triglycerides Increased for Women aged 20-29 - 16 seconds ago
- Xeljanz and Hypercholesterolaemia for Women aged 20-29 - 16 seconds ago
- Xeljanz and Blood Triglycerides Abnormal for Women aged 20-29 - 17 seconds ago